D&D Pharmatech (347850.KQ)
KRW 47200.0
(0.21%)
KRW 47200.0
(0.21%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 18.67 Billion | 610.56 Million | 1.36 Billion | - | - |
| Cost of Revenue | - | 31.35 Million | 26.08 Million | 43.06 Million | 13.92 Million |
| Gross Profit | 18.67 Billion | 579.21 Million | 1.33 Billion | -43.06 Million | -13.92 Million |
| Operating Expenses | 32.16 Billion | 69.26 Billion | 77.04 Billion | 69.1 Billion | 4.52 Billion |
| Selling, General and Administrative Expenses | 2.23 Billion | 2.02 Billion | 2.35 Billion | 2.03 Billion | 4.01 Billion |
| Research and Development Expenses | 19.97 Billion | 47.12 Billion | 56.82 Billion | 50.8 Billion | 19.55 Billion |
| Other Expenses | 9.95 Billion | 549.87 Million | 336 Million | 718.07 Million | - |
| Cost and Expenses | 32.16 Billion | 69.26 Billion | 77.04 Billion | 69.1 Billion | 4.54 Billion |
| Operating Income | -13.48 Billion | -68.65 Billion | -75.67 Billion | -69.1 Billion | -31.13 Billion |
| Interest Expense | 1.42 Billion | 2.95 Billion | 1.01 Billion | 5.71 Billion | - |
| Income Tax Expense | 1.06 Billion | -26.48 Billion | -2.18 Billion | -2.71 Billion | 1.96 Billion |
| Earnings before Tax | 4.49 Billion | -163.51 Billion | -72.04 Billion | -66.99 Billion | -8.38 Billion |
| Net Income | 3.93 Billion | -136.06 Billion | -68.22 Billion | -63.4 Billion | -6.35 Billion |
| Earnings Per Share Basic | 409.19 | -16.88 Thousand | -8483.00 | -9097.00 | -1901.00 |
| Earnings Per Share Diluted | 419.36 | -14.53 Thousand | -8695.00 | -9400.00 | -1901.00 |
| Weighted Average Shares Outstanding | 9.61 Million | 8.05 Million | 8.04 Million | 6.96 Million | 3.34 Million |
| Weighted Average Shares Outstanding (Diluted) | 9.38 Million | 9.35 Million | 7.84 Million | 6.74 Million | 3.34 Million |
| Gross Margin | 1.00 | 0.95 | 0.98 | - | - |
| EBIT Margin | -0.48 | -148.84 | -46.14 | - | - |
| Profit Margin | 0.21 | -222.85 | -50.01 | - | - |
| EBITDA | -9.05 Billion | -90.87 Billion | -62.93 Billion | -56.56 Billion | -23.27 Billion |
| Earnings Before Tax Margin | -0.72 | -112.44 | -55.48 | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 2.31 Billion | 2.22 Billion | 1.8 Billion | 18.67 Billion | 6.99 Billion | 9.7 Billion |
| Cost of Revenue | 4.08 Million | 3.95 Million | 4.01 Million | - | - | - |
| Gross Profit | 2.31 Billion | 2.21 Billion | 1.8 Billion | 18.67 Billion | 6.99 Billion | 9.7 Billion |
| Operating Expenses | 8.26 Billion | 6.58 Billion | 5.78 Billion | 32.16 Billion | 7 Billion | 5.18 Billion |
| Selling, General and Administrative Expenses | 686.55 Million | 1.92 Billion | 568.11 Million | - | 548.17 Million | 217.34 Million |
| Research and Development Expenses | 5.09 Billion | 4.65 Billion | 3.06 Billion | - | 4.41 Billion | 2.83 Billion |
| Other Expenses | 188.23 Million | - | 248.98 Million | 624.81 Million | 102.6 Million | 25.89 Million |
| Cost and Expenses | 8.26 Billion | 6.58 Billion | 5.78 Billion | 32.16 Billion | 7 Billion | 5.18 Billion |
| Operating Income | -5.94 Billion | -4.36 Billion | -3.97 Billion | -13.48 Billion | -9.59 Million | 4.51 Billion |
| Interest Expense | 150.48 Million | - | 154.09 Million | 1.42 Billion | 150.36 Million | 312.54 Million |
| Income Tax Expense | -222.03 Million | 218.62 Million | -213.95 Million | 1.06 Billion | -212.38 Million | 1.7 Billion |
| Earnings before Tax | -6.14 Billion | -5.97 Billion | 198.01 Million | 4.49 Billion | -167.79 Million | 19.16 Billion |
| Net Income | -5.78 Billion | -5.61 Billion | 511.86 Million | 3.93 Billion | 174.74 Million | 17.58 Billion |
| Earnings Per Share Basic | -569.00 | -577.33 | 55.02 | - | 18.82 | 1963.00 |
| Earnings Per Share Diluted | -569.00 | -577.33 | 53.24 | - | 18.82 | 287.00 |
| Weighted Average Shares Outstanding | 10.16 Million | 9.72 Million | 9.61 Million | 9.61 Million | 9.28 Million | 8.95 Million |
| Weighted Average Shares Outstanding (Diluted) | 10.16 Million | 9.72 Million | 9.58 Million | 9.61 Million | - | 61.27 Million |
| Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | -2.12 | -1.90 | -1.68 | - | 0.14 | 0.54 |
| Profit Margin | -2.50 | -2.53 | 0.28 | 0.21 | 0.02 | 1.81 |
| EBITDA | -4.91 Billion | -4.22 Billion | -3.02 Billion | - | 959.46 Million | 5.19 Billion |
| Earnings Before Tax Margin | -2.57 | -1.96 | -2.20 | -0.72 | -0.00 | 0.47 |
RMC
1936
SKL
SCPH
PCPDF
HRB